Breast Cancer Clinical Trials in Hangzhou, Zhejiang
31 recruitingHangzhou, Zhejiang, China
Showing 1–20 of 31 trials
Recruiting
Not Applicable
Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases
Breast CancerRadiotherapy
Fudan University1,608 enrolled15 locationsNCT07469267
Recruiting
Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence
Breast CancerBreastPathology
Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 enrolled1 locationNCT07252986
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University400 enrolled4 locationsNCT07244094
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Pfizer400 enrolled153 locationsNCT07062965
Recruiting
Not Applicable
Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study
Breast Cancer
Tian'an Jiang24 enrolled2 locationsNCT07263451
Recruiting
Phase 1
A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors
Breast CancerNSCLC (Advanced Non-small Cell Lung Cancer)
Second Affiliated Hospital, School of Medicine, Zhejiang University48 enrolled1 locationNCT07250386
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Phase 1
A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors
Breast CancerLocally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.26 enrolled7 locationsNCT05461768
Recruiting
Phase 3
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Breast Cancer
Laekna Limited256 enrolled55 locationsNCT04851613
Recruiting
Phase 2
Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer
Breast Cancer
Zhejiang Cancer Hospital63 enrolled1 locationNCT07014410
Recruiting
Not Applicable
Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
Breast CancerSurgeryLymph Node Metastases
Second Affiliated Hospital, School of Medicine, Zhejiang University126 enrolled1 locationNCT04744506
Recruiting
Not Applicable
Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University60 enrolled1 locationNCT06741540
Recruiting
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer
Breast CancerNeoadjuvant ChemotherapyOrganoids
Second Affiliated Hospital, School of Medicine, Zhejiang University58 enrolled1 locationNCT06155305
Recruiting
Not Applicable
Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction
Breast Cancer
Fudan University80 enrolled6 locationsNCT05512286
Recruiting
Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University286 enrolled1 locationNCT06587789
Recruiting
Phase 2
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.42 enrolled16 locationsNCT06452706
Recruiting
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
Breast CancerMeasurable Residual Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University80 enrolled1 locationNCT06595966
Recruiting
Not Applicable
The Impact of Respiratory Training of DIBH Radiotherapy for Breast Cancer
Breast Cancer
Jianjun Lai80 enrolled1 locationNCT06488391